These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14656995)

  • 1. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides.
    Nekhotiaeva N; Elmquist A; Rajarao GK; Hällbrink M; Langel U; Good L
    FASEB J; 2004 Feb; 18(2):394-6. PubMed ID: 14656995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects.
    Palm C; Netzereab S; Hällbrink M
    Peptides; 2006 Jul; 27(7):1710-6. PubMed ID: 16500001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs.
    Nan YH; Park IS; Hahm KS; Shin SY
    J Pept Sci; 2011 Dec; 17(12):812-7. PubMed ID: 21956793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pVEC hydrophobic N-terminus is critical for antibacterial activity.
    Alaybeyoglu B; Sariyar Akbulut B; Ozkirimli E
    J Pept Sci; 2018 Jun; 24(6):e3083. PubMed ID: 29737576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
    Herbig ME; Assi F; Textor M; Merkle HP
    Biochemistry; 2006 Mar; 45(11):3598-609. PubMed ID: 16533042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial activity of Sub3 is dependent on membrane binding and cell-penetrating ability.
    Torcato IM; Huang YH; Franquelim HG; Gaspar DD; Craik DJ; Castanho MA; Henriques ST
    Chembiochem; 2013 Oct; 14(15):2013-22. PubMed ID: 24038773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP.
    Eggimann GA; Buschor S; Darbre T; Reymond JL
    Org Biomol Chem; 2013 Oct; 11(39):6717-33. PubMed ID: 23933745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides.
    Nicolas P
    FEBS J; 2009 Nov; 276(22):6483-96. PubMed ID: 19817856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides and antimicrobial peptides: how different are they?
    Henriques ST; Melo MN; Castanho MA
    Biochem J; 2006 Oct; 399(1):1-7. PubMed ID: 16956326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
    Hale JD; Hancock RE
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro uptake and stability study of pVEC and its all-D analog.
    Elmquist A; Langel U
    Biol Chem; 2003 Mar; 384(3):387-93. PubMed ID: 12715889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
    Papo N; Shai Y
    Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free uptake of cell-penetrating peptides by fission yeast.
    Parenteau J; Klinck R; Good L; Langel U; Wellinger RJ; Elela SA
    FEBS Lett; 2005 Aug; 579(21):4873-8. PubMed ID: 16111683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
    Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
    J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides: a comparative membrane toxicity study.
    Saar K; Lindgren M; Hansen M; Eiríksdóttir E; Jiang Y; Rosenthal-Aizman K; Sassian M; Langel U
    Anal Biochem; 2005 Oct; 345(1):55-65. PubMed ID: 16137634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.